0001689813-19-000118.txt : 20191218 0001689813-19-000118.hdr.sgml : 20191218 20191218213931 ACCESSION NUMBER: 0001689813-19-000118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191216 FILED AS OF DATE: 20191218 DATE AS OF CHANGE: 20191218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AGUIAR ERIC CENTRAL INDEX KEY: 0001262325 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38080 FILM NUMBER: 191294012 MAIL ADDRESS: STREET 1: 888 7TH AVENUE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd. CENTRAL INDEX KEY: 0001689813 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-404-0410 MAIL ADDRESS: STREET 1: 215 CHURCH STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 wf-form4_157672315313106.xml FORM 4 X0306 4 2019-12-16 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001262325 AGUIAR ERIC C/O AISLING CAPITAL LLC 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 1 0 0 0 Common Shares 2019-12-16 4 M 0 3537 20.79 A 3537 I By Spouse Common Shares 2019-12-16 4 S 0 3537 55.1271 D 0 I By Spouse Employee Stock Option (Right to Buy) 20.79 2019-12-16 4 M 0 3537 0 D 2027-12-06 Common Shares 3537.0 15218 I By Spouse These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person's spouse. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.00 - $55.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The option, representing a right to purchase a total of 30,436 shares was granted on December 7, 2017, vesting in four equal installments on December 7, 2018, 2019, 2020 and 2021, subject to the optionholder's continuous service with the Issuer at each vesting date. The optionholder previously exercised the option with respect to 7,609 shares on February 4, 2019 and 4,072 shares on December 9, 2019. This employee stock option is held by the Reporting Person's spouse. /s/ Jim Engelhart, Attorney-in-fact 2019-12-18